Advances in understanding the molecular basis of FXTAS

Dolores Garcia-Arocena, Paul J Hagerman

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. The clinical features of FXTAS, as well as other forms of clinical involvement in carriers without FXTAS, are thought to arise from a toxic gain of function of transcriptionally active FMR1 containing expanded CGG repeats. Although the precise mechanisms involved in rCGG toxicity are unknown, here we discuss the latest advances and models that contribute to the understanding of the molecular basis of FXTAS, and the emerging view of FXTAS as the end-stage of a process that begins in early development.

Original languageEnglish (US)
Article numberddq166
JournalHuman Molecular Genetics
Volume19
Issue numberR1
DOIs
StatePublished - Apr 29 2010

Fingerprint

Intellectual Disability
Poisons
Neurodegenerative Diseases
Fragile X Tremor Ataxia Syndrome
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Advances in understanding the molecular basis of FXTAS. / Garcia-Arocena, Dolores; Hagerman, Paul J.

In: Human Molecular Genetics, Vol. 19, No. R1, ddq166, 29.04.2010.

Research output: Contribution to journalArticle

@article{9b1bd62d33b64ed6bd138a4de2394984,
title = "Advances in understanding the molecular basis of FXTAS",
abstract = "Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. The clinical features of FXTAS, as well as other forms of clinical involvement in carriers without FXTAS, are thought to arise from a toxic gain of function of transcriptionally active FMR1 containing expanded CGG repeats. Although the precise mechanisms involved in rCGG toxicity are unknown, here we discuss the latest advances and models that contribute to the understanding of the molecular basis of FXTAS, and the emerging view of FXTAS as the end-stage of a process that begins in early development.",
author = "Dolores Garcia-Arocena and Hagerman, {Paul J}",
year = "2010",
month = "4",
day = "29",
doi = "10.1093/hmg/ddq166",
language = "English (US)",
volume = "19",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "R1",

}

TY - JOUR

T1 - Advances in understanding the molecular basis of FXTAS

AU - Garcia-Arocena, Dolores

AU - Hagerman, Paul J

PY - 2010/4/29

Y1 - 2010/4/29

N2 - Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. The clinical features of FXTAS, as well as other forms of clinical involvement in carriers without FXTAS, are thought to arise from a toxic gain of function of transcriptionally active FMR1 containing expanded CGG repeats. Although the precise mechanisms involved in rCGG toxicity are unknown, here we discuss the latest advances and models that contribute to the understanding of the molecular basis of FXTAS, and the emerging view of FXTAS as the end-stage of a process that begins in early development.

AB - Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder among carriers of premutation expansions (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. The clinical features of FXTAS, as well as other forms of clinical involvement in carriers without FXTAS, are thought to arise from a toxic gain of function of transcriptionally active FMR1 containing expanded CGG repeats. Although the precise mechanisms involved in rCGG toxicity are unknown, here we discuss the latest advances and models that contribute to the understanding of the molecular basis of FXTAS, and the emerging view of FXTAS as the end-stage of a process that begins in early development.

UR - http://www.scopus.com/inward/record.url?scp=77953884301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953884301&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddq166

DO - 10.1093/hmg/ddq166

M3 - Article

VL - 19

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - R1

M1 - ddq166

ER -